Rapid Readouts: Updated data from a pooled analysis of larotrectinib in TRK fusion-positive cancers
July 1st 2021Alexander Drilon, MD presents updated results from a pooled analysis of TRK fusion-positive cancers treated with larotrectinib from the 2021 American Society of Clinical Oncology annual meeting.
Read More